Life ScienceCompany
TetraLogic Pharmaceuticals - Oncology Programs Ownership
Who owns TetraLogic Pharmaceuticals - Oncology Programs?
TetraLogic Pharmaceuticals - Oncology Programs is owned by Medivir AB. It was acquired on December 29, 2016.
TetraLogic Pharmaceuticals - Oncology Programs Business Overview
Where is TetraLogic Pharmaceuticals - Oncology Programs headquartered?
TetraLogic Pharmaceuticals - Oncology Programs is headquartered in Malvern, Pennsylvania.
What sector is TetraLogic Pharmaceuticals - Oncology Programs in?
TetraLogic Pharmaceuticals - Oncology Programs is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.